We also identified the clinical data and molecular mutation profiles of GBM patients from the TCGA database by consulting previously literature,5 including age, overall survival, survival status, TERT promoter mutations, chromosome 1p/19q codeletion, chromosome 7 gain and 10 loss, MGMT promoter methylation, and BRAF V600E mutation. Here, BRAF is linked to glioblastoma.